회원가입 | 연락처 | 사이트맵 | English       회사소개 | 리포트 | 커스텀 리서치 | 고객지원 리포트검색 정보제휴업체

로그인 카테고리 유/무선통신 전기/전자 디지털기기/미디어/방송 Information Technology 에너지 생명공학 화학/신소재 자동차 환경 일반소비재 마케팅/광고 금융 건설 교통/운송 소비자조사 방위/항공/우주 식음료 중공업 교육 기계 무역 스포츠/레저 해운/조선 패션 정부/정책 공예/귀금속 컴퍼니 프로파일 기타산업 무선통신 유선통신 차세대통신 홈네트워크 휴대폰/단말기 RFID IPTV/VoIP 통신융합 통신장비/네트워크 광통신/위성통신 국가별통신시장 기타 전자부품 디스플레이 반도체 조명/LED 로봇 센서 레이저 MEMS Embedded Software SoC 기타 디지털기기/가전 차세대정보기기 휴대용미디어기기 디지털컨텐츠 게임 방송/미디어/엔터테인먼트 STB 기타 e-Commerce e-Learning 보안 소프트웨어/서비스 인터넷 시스템장비 IT기술 기타 태양광발전 신/재생에너지 연료전지 배터리 전기/발전 석유/가스 에너지일반 기타 Digital Health/e-Health 바이오테크놀로지 생체인식 의료장비 제약 진단 헬스케어 기타 나노 신소재/신기술 플라스틱 섬유 폴리머 세라믹 금속/광물 화학 기타 전장 전자부품 텔레메틱스 전기자동차 자동차용품/산업 기타 리사이클 수처리 공기 오염 기타

현재위치 : HOME > 리포트 > 생명공학 > 제약 Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2015 발행사 GlobalData 발행일 2015-05 분량 140 pages 서비스형태 Report 판매가격 PDF Single User : $1,500 PDF Department: $3,000 PDF Corporate : $4,500 인쇄하기 Table of Contents 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q1 2015 2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q1 2015 2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q1 2015 2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q1 2015 2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q1 2015 2.4.1 AbbVie to Acquire Pharmacyclics for USD21 Billion 2.4.2 Actavis Raises USD21 Billion in Public Offering of Senior Notes 2.4.3 Pfizer to Acquire Hospira for USD17 Billion 2.4.4 UnitedHealth to Acquire Catamaran for USD12.8 Billion 2.4.5 Valeant Pharma Acquires Salix Pharma for USD10.9 Billion 3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 3.1 Pharmaceuticals & Healthcare, Global, M&A, Q1 2015 3.1.1 Top M&A Deals in Q1 2015 3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q1 2014 - Q1 2015 3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q1 2015 3.2.1 Top Initial Public Offerings in Q1 2015 3.2.2 Top Secondary Offerings in Q1 2015 3.2.3 Top PIPE Deals in Q1 2015 3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q1 2014-Q1 2015 3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q1 2014 - Q1 2015 3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q1 2015 3.3.1 Top Venture Financing Deals in Q1 2015 3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q1 2015 3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q1 2015 3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q1 2014 - Q1 2015 3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q1 2014 - Q1 2015 3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q1 2014 - Q1 2015 3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q1 2015 3.4.1 Top Private Equity Deals in Q1 2015 3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q1 2014 - Q1 2015 4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2015 4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2015 4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q1 2014 - Q1 2015 4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2015 4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q1 2015 4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q1 2015 4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q1 2015 4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2014 - Q1 2015 4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q1 2014 - Q1 2015 4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q1 2014 - Q1 2015 4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2014 - Q1 2015 5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q1 2015 5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q1 2015 5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2014 - Q1 2015 5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q1 2015 5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q1 2015 5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q1 2015 5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q1 2014 - Q1 2015 5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q1 2014 - Q1 2015 5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2014 - Q1 2015 5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2014 - Q1 2015 5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q1 2014 - Q1 2015 6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q1 2014 - Q1 2015 6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q1 2014 - Q1 2015 6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q1 2014 - Q1 2015 6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q1 2014 - Q1 2015 6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q1 2014 - Q1 2015 6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q1 2014 - Q1 2015 6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q1 2014 - Q1 2015 7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q1 2015 7.1.1 Oncology - Deals of the Quarter 7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q1 2015 7.2.1 Central Nervous System - Deals of the Quarter 7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q1 2015 7.3.1 Infectious Disease - Deals of the Quarter 7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q1 2015 7.4.1 Immunology - Deals of the Quarter 7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q1 2015 7.5.1 Metabolic Disorders - Deals of the Quarter 7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q1 2015 7.6.1 Cardiovascular - Deals of the Quarter 7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q1 2015 7.7.1 Gastrointestinal - Deals of the Quarter 7.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q1 2015 7.8.1 Dermatology - Deals of the Quarter 7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q1 2015 7.9.1 Respiratory - Deals of the Quarter 7.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q1 2015 7.10.1 Ophthalmology - Deals of the Quarter 8 Deal Summary by Geography 8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q1 2015 8.1.1 North America - Deals of the Quarter 8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q1 2015 8.2.1 Europe - Deals of the Quarter 8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q1 2015 8.3.1 Asia-Pacific - Deals of the Quarter 8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q1 2015 8.4.1 Rest of the World - Deals of the Quarter 9 Pharmaceuticals & Healthcare, Global, Top Advisors 9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q1 2014 - Q1 2015 9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q1 2014 - Q1 2015 10 Appendix 11 Further Information 11.1 Methodology 11.2 About GlobalData 11.3 Disclosure information 11.4 Disclaimer List of Tables Table 1: Pharmaceuticals & Healthcare, Global, Deal Summary, Number of Deals and Deal Values (US$m), Q1 2014 - Q1 2015 Table 2: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), Q1 2015 Table 3: Pharmaceuticals & Healthcare, Global, Top Deals, Q1 2015 Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, Q1 2015 Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, , Q1 2014 - Q1 2015 Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2014 - Q1 2015 Table 8: Pharmaceuticals & Healthcare, Global, Top Initial Public Offering Deals, Q1 2015 Table 9: Pharmaceuticals & Healthcare, Global, Top Secondary Offering Deals, Q1 2015 Table 10: Pharmaceuticals & Healthcare, Global, Top PIPE Deals, Q1 2015 Table 11: Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q1 2014-Q1 2015 Table 12: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2014 - Q1 2015 Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Capital Deals, Q1 2015 Table 15: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), Q1 2015 Table 16: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2014 - Q1 2015 Table 17: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 18: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q1 2014 - Q1 2015 Table 19: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 20: Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, Q1 2015 Table 21: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2014 - Q1 2015 Table 22: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 23: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 24: Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 25: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2015 Table 26: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q1 2015 Table 27: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, Q1 2015 Table 28: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 29: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2014 - Q1 2015 Table 30: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 31: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deal Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 32: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 33: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Deal Values, Q1 2015 Table 34: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Upfront Payment, Q1 2015 Table 35: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Milestone Payment, Q1 2015 Table 36: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 37: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment (US$ m), Q1 2014 - Q1 2015 Table 38: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2014 - Q1 2015 Table 39: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 40: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value vs Median Deal Value, (US$m), Q1 2014 - Q1 2015 Table 41: Pharmaceuticals & Healthcare, Global Acquisitions, Average P/E of Acquired Companies, Q1 2014 - Q1 2015 Table 42: Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q1 2014 - Q1 2015 Table 43: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Operating Profit, Q1 2014 - Q1 2015 Table 44: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share vs Average Market Price Per Share, Q1 2014 - Q1 2015 Table 45: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share vs Average Book Value Per Share, Q1 2014 - Q1 2015 Table 46: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q1 2014 - Q1 2015 Table 47: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 48: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 49: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 50: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 51: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 52: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 53: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 54: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 55: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 56: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 57: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 58: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 59: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 60: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 61: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 62: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Table 63: Pharmaceuticals & Healthcare, Deals’ Key Financials, Global Acquisition Deals, Q1 2014-Q1 2015 List of Figures Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$m), Q1 2014 - Q1 2015 Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), Q1 2015 Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), Q1 2015 Figure 4: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$m), Q1 2014 - Q1 2015 Figure 5: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$m), by Therapy Area, Q1 2014 - Q1 2015 Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$m), , Q1 2014 - Q1 2015 Figure 8: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 9: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), Q1 2015 Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), Q1 2015 Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q1 2014 - Q1 2015 Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 13: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 14: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q1 2014 - Q1 2015 Figure 15: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2014 - Q1 2015 Figure 20: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2014 - Q1 2015 Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number Of Deals, Q1 2014 - Q1 2015 Figure 27: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 29: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value vs Median Deal Value, (US$m), Q1 2014 - Q1 2015 Figure 30: Pharmaceuticals & Healthcare, Global Acquisitions, Average P/E of Acquired Companies, Q1 2014 - Q1 2015 Figure 31: Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q1 2014 - Q1 2015 Figure 32: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q1 2014 - Q1 2015 Figure 33: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share vs Average Market Price Per Share, Q1 2014 - Q1 2015 Figure 34: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share vs Average Book Value Per Share, Q1 2014 - Q1 2015 Figure 35: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q1 2014 - Q1 2015 Figure 36: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 37: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 38: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 39: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 40: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 41: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 42: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 43: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 44: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 45: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 46: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 47: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 122 Figure 48: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 49: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 50: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015 Figure 51: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q1 2014 - Q1 2015

회사소개 | 개인정보보호정책 | 이용약관 | 배송/결제안내 | 이용안내
		서울시 강남구 논현동 210-1 삼원빌딩 | 회사명 : (주)엘앤에치 대표전화 : 02-554-0001 / 팩스 : 02-3444-5501 / 이메일 : sales@landh.co.kr Copyright ⓒ 2008 LNH, Inc. All rights reserved.